Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis

Naim Shehadeh, Shirly Pollack, Gizi Wildbaum, Yaniv Zohar, Itay Shafat, Reem Makhoul, Essam Daod, Fahed Hakim, Rina Perlman, Nathan Karin

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis'. Together they form a unique fingerprint.

Immunology and Microbiology

Keyphrases